Literature DB >> 26623050

Thymoma exhibiting spontaneous regression in size, pleural effusion and serum cytokeratin fragment level: A case report.

Kenta Furuya1, Kazutoshi Isobe1, G O Sano1, Kyohei Kaburaki1, Kyoko Gocho1, Fumiaki Ishida1, Naoshi Kikuchi1, Keishi Sugino1, Susumu Sakamoto1, Yujiro Takai1, Hajime Otsuka2, Yoshinobu Hata2, Akira Iyoda2, Megumi Wakayama3, Kazutoshi Shibuya3, Sakae Homma1.   

Abstract

A 30-year-old man was admitted to Toho University Omori Medical Center for assessment of right chest pain and fever. Chest computed tomography (CT) revealed an anterior mediastinal tumor sized 11.0×6.0×5.0 cm, with right pleural effusion. The laboratory analysis revealed elevated white blood cell count (11,000/µl), C-reactive protein (4.1 mg/dl) and cytokeratin fragment (CYFRA; 12.7 ng/ml; normal, <2 ng/ml). The level of CYFRA in the pleural effusion was also markedly elevated (143 ng/ml). On the first day after admission (6 days after the initial CT), there was a mild regression on CT (10.0×5.5×4.4 cm; reduction rate, 26.7%), with decrease of the pleural effusion volume. A CT-guided needle biopsy was performed, but the findings were not conclusive, as most of the tissue was necrotic. Seven days later (13 days after the initial CT), a CT revealed further regression (9.5×5.4×4.2 cm; reduction rate, 34.7%) with disappearance of the pleural effusion. The patient was followed up on an outpatient basis. At 35 days after the initial CT, the tumor continued to shrink without treatment (8.0×3.6×3.0 cm; reduction rate, 73.8%) and the serum CYFRA level had decreased to 0.8 ng/ml, although it had not returned to normal levels. At 62 days after the initial CT, the patient underwent surgical resection. The resected specimen was diagnosed as thymoma (World Health Organization type B2; Masaoka classification, stage II), with prominent degeneration and necrosis. One possible cause of the spontaneous regression may be increased internal pressure, probably associated with rapid tumor growth, leading to massive necrosis with resulting chest pain, inflammatory reaction with pleural effusion and subsequent tumor regression. The serum CYFRA level may be a useful marker for the evaluation of the clinical course of thymoma with extensive necrosis.

Entities:  

Keywords:  cytokeratin fragment; necrosis; pleural effusion; spontaneous regression; thymoma

Year:  2015        PMID: 26623050      PMCID: PMC4535058          DOI: 10.3892/mco.2015.583

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  16 in total

1.  Sclerosing thymoma--a possible phenomenon of regression.

Authors:  T Kuo
Journal:  Histopathology       Date:  1994-09       Impact factor: 5.087

2.  Cytokeratin-19 fragment (CYFRA 21-1) in bladder cancer.

Authors:  T Morita; T Kikuchi; S Hashimoto; Y Kobayashi; A Tokue
Journal:  Eur Urol       Date:  1997       Impact factor: 20.096

3.  True cytokeratin 8/18 immunohistochemistry is of no use in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray study.

Authors:  Jeng-Dong Hsu; Chung-Chin Yao; Ming-Yung Lee; Lai-Fong Kok; Po-Hui Wang; Yeu-Sheng Tyan; Chin-Ping Han
Journal:  Int J Gynecol Pathol       Date:  2010-05       Impact factor: 2.762

4.  Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies.

Authors:  Eric A Engels; Ruth M Pfeiffer
Journal:  Int J Cancer       Date:  2003-07-01       Impact factor: 7.396

Review 5.  Malignant thymoma: current status of classification and multimodality treatment.

Authors:  I G H Schmidt-Wolf; J K Rockstroh; H Schüller; A Hirner; C Grohe; H K Müller-Hermelink; D Huhn
Journal:  Ann Hematol       Date:  2003-02-11       Impact factor: 3.673

6.  "Ancient" (sclerosing) thymomas: a clinicopathologic study of 10 cases.

Authors:  Cesar A Moran; Saul Suster
Journal:  Am J Clin Pathol       Date:  2004-06       Impact factor: 2.493

Review 7.  Efforts to explain spontaneous regression of cancer.

Authors:  W H Cole
Journal:  J Surg Oncol       Date:  1981       Impact factor: 3.454

8.  Thymoma with spontaneous regression and disappearance of pleural effusion.

Authors:  Takehiko Okagawa; Tatsuo Uchida; Motokazu Suyama
Journal:  Gen Thorac Cardiovasc Surg       Date:  2007-12-11

9.  CYFRA 21-1, a sensitive and specific new tumour marker for squamous cell lung cancer. Report of the first European multicentre evaluation. CYFRA 21-1 Multicentre Study Group.

Authors:  D Rastel; A Ramaioli; F Cornillie; B Thirion
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

10.  Thymoma in myasthenia gravis: from diagnosis to treatment.

Authors:  Fredrik Romi
Journal:  Autoimmune Dis       Date:  2011-08-10
View more
  1 in total

1.  Transcutaneous B-mode ultrasound (TUS) and contrast-enhanced ultrasound (CEUS) pattern of mediastinal tumors: a pictorial essay.

Authors:  Ehsan Safai Zadeh; Christoph Frank Dietrich; Corinna Trenker; Amjad Alhayri; Christian Görg
Journal:  J Ultrason       Date:  2021-12-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.